Role of FDG PET in the management of childhood lymphomas--case proven or is the jury still out?
Positron emission tomography (PET) is a novel non invasive functional imaging modality that is increasingly used for the primary staging of lymphomas and assessment of therapeutic response. This review evaluates the published reports of its use in childhood lymphomas, particularly in the primary staging, response assessment and monitoring after completion of treatment. Specific attention is focused on the clinical circumstances in which FDG PET is most likely to have an impact on management and some indications for its use in childhood lymphomas are suggested.
Shankar
Ananth
A
Department of Paediatric and Adolescent Oncology, 6th Floor Central, University College London Hospitals NHS Foundation Trust, 250 Euston Road, London, UK. ananth.shankar@uclh.nhs.uk
Fiumara
Frank
F
Pinkerton
Ross
R
D002648:Child; D005189:False Positive Reactions; D019788:Fluorodeoxyglucose F18; D005710:Gallium Radioisotopes; D006801:Humans; D008223:Lymphoma / Q000000981:diagnostic imaging*; D009367:Neoplasm Staging / Q000379:methods; D049268:Positron-Emission Tomography / Q000379:methods*; D019275:Radiopharmaceuticals
D005710:Gallium Radioisotopes; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18